Stay updated with breaking news from Mark Vignola. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
FOSTER CITY, Calif., Aug. 03, 2023 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to
Senthil Sundaram Stepping Down as Chief Executive Officer for Health Reasons...
27.03.2023 - - Announces key appointments in oncology R&D and business development functions - Cash and cash equivalents of $283 million expected to provide runway into 2026 FOSTER CITY, Calif., March 27, 2023 (GLOBE NEWSWIRE) - Terns Pharmaceuticals, ...
Terns Pharmaceuticals, Inc. Announces Pricing of Upsized Initial Public Offering of Common Stock FOSTER CITY, Calif., Feb. 04, 2021 (GLOBE NEWSWIRE) — Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, or NASH, and other chronic liver diseases, today announced the pricing of its upsized initial public offering of 7,500,000 shares of common stock at a public offering price of $17.00 ...